These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11790489)

  • 21. Quantitative study of electrophoretic and electroosmotic enhancement during alternating current iontophoresis across synthetic membranes.
    Yan G; Li SK; Peck KD; Zhu H; Higuchi WI
    J Pharm Sci; 2004 Dec; 93(12):2895-908. PubMed ID: 15459891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport behavior of hairless mouse skin during constant current DC iontophoresis, part 2: iontophoresis of nonionic molecules with cotransport of polystyrene sulfonate oligomers.
    Liddell MR; Li SK; Higuchi WI
    J Pharm Sci; 2011 Jul; 100(7):2816-25. PubMed ID: 21455977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of porosity changes in human epidermal membrane during iontophoresis on the permeability enhancement of a model peptide.
    Smyth HD; Becket G; Mehta S
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1201-9. PubMed ID: 19555248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pore charge distribution considerations in human epidermal membrane electroosmosis.
    Li SK; Ghanem AH; Higuchi WI
    J Pharm Sci; 1999 Oct; 88(10):1044-9. PubMed ID: 10514354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flux enhancement effects of ionic surfactants upon passive and electroosmotic transdermal transport.
    Peck KD; Hsu J; Li SK; Ghanem AH; Higuchi WI
    J Pharm Sci; 1998 Sep; 87(9):1161-9. PubMed ID: 9724571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of iontophoresis and jet injector pretreatment on the in-vitro skin permeation of diclofenac and angiotensin II.
    Sugibayashi K; Kagino M; Numajiri S; Inoue N; Kobayashi D; Kimura M; Yamaguchi M; Morimoto Y
    J Pharm Pharmacol; 2000 Oct; 52(10):1179-86. PubMed ID: 11092561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulated drug release using iontophoresis through heterogeneous cation-exchange membranes. 2. Influence of cation-exchanger content on membrane resistance and characteristic times.
    Schwendeman SP; Amidon GL; Labhasetwar V; Levy RJ
    J Pharm Sci; 1994 Oct; 83(10):1482-94. PubMed ID: 7884674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes.
    Imanidis G; Luetolf P
    J Pharm Sci; 2006 Jul; 95(7):1434-47. PubMed ID: 16724334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport of ionic species in skin: contribution of pores to the overall skin conductance.
    Scott ER; Laplaza AI; White HS; Phipps JB
    Pharm Res; 1993 Dec; 10(12):1699-709. PubMed ID: 8302754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro iontophoretic delivery of nicorandil.
    Ghosh B; Baser R; Patil UA; Dinesh BM
    PDA J Pharm Sci Technol; 2010; 64(1):20-7. PubMed ID: 21502000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
    Altenbach M; Schnyder N; Zimmermann C; Imanidis G
    Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrically induced transport of macromolecules through oral buccal mucosa.
    Patel MP; Churchman ST; Cruchley AT; Braden M; Williams DM
    Dent Mater; 2013 Jun; 29(6):674-81. PubMed ID: 23582693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of skin permeation-enhancing mechanism of iontophoresis using hydrodynamic pore theory.
    Manabe E; Numajiri S; Sugibayashi K; Morimoto Y
    J Control Release; 2000 May; 66(2-3):149-58. PubMed ID: 10742576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of iontophoresis on skin permeation of defibrase.
    Zhao HY; Yuan QP; Zheng JM
    Yao Xue Xue Bao; 2005 Feb; 40(2):178-81. PubMed ID: 15875678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.
    Bommannan DB; Tamada J; Leung L; Potts RO
    Pharm Res; 1994 Dec; 11(12):1809-14. PubMed ID: 7899247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of electroporation and iontophoresis on skin permeation of Defibrase--a purified thrombin-like enzyme from the venom of Agkistrodon halys ussuriensis Emelianov.
    Zhao HY; Zheng JM; Pan Y; Song JD
    Pharmazie; 2002 Jul; 57(7):482-4. PubMed ID: 12168531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance.
    Craane-van Hinsberg WH; Bax L; Flinterman NH; Verhoef J; Junginger HE; Boddé HE
    Pharm Res; 1994 Sep; 11(9):1296-300. PubMed ID: 7816759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.